Hospital
The First Affiliated Hospital of Nanchang University南昌大学第一附属医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++ General list, 2023
-
Published research 14 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 7 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 南昌大学第一附属医院
- English name
- The First Affiliated Hospital of Nanchang University
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Secreted PEBP4 promotes colorectal cancer progression via regulation of the TGF-β signaling pathway. Cancer letters, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Breast cancer
Published research
- Multiparametric MRI-Based Interpretable Machine Learning Radiomics Model for Predicting Neoadjuvant Chemotherapy Sensitivity and Recurrence-Free Survival in Breast Cancer. Academic radiology, 2026
- MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis. Research (Washington, D.C.), 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Lung cancer
Published research
- Epidemiological characteristics and risk factors of lung cancer in a population with incidental pulmonary nodules in China: a prospective multicenter study of 10,560 cases. Journal of the National Cancer Center, 2026
- The shifting burden of tracheal, bronchus and lung cancer in ageing Asia: structural drivers and projections to 2050. Annals of medicine, 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Liver cancer
Published research
- Dynamic Vascular Spatiotemporal Heterogeneity on Multiphase CT for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma, 2026
- Mitochondrial Quality Regulation Genes as Prognostic Markers in Hepatocellular Carcinoma: Tumor Microenvironment, Therapeutic Response, and Drug Sensitivity Analysis. Drug development research, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Cervical cancer
Published research
- Targeting the KIFC1-SRSF3-PKM Axis Suppresses Cervical Cancer Glycolysis and Enhances Radiosensitivity. Journal of cellular and molecular medicine, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Stomach cancer
Published research
- Correction: IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Urology nominated, Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Prostate cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Also ranked: Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Bladder cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Also ranked: Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
-
Kidney cancer
Fudan specialty reputation ranking 2023
- Urology nominated https://www.fdygs.com/news2023-1.aspx
Also ranked: Gastroenterology nominated, Nuclear Medicine 核医学 nominated in the Fudan list.
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24